The Latest Psychedelics Articles from Streetwise Reports

Drug Reform Streaming Co. Starts Trading on CSE

  ()
This company investing in and incubating companies at the forefront of drug policy reform has started trading on the Canadian Securities Exchange. One writer says buying stock is a chance to be a part of a "movement."

Biotech Co. Makes Strides on Three Fronts

Research Report
  ()
This Canadian firm sold assets, launched an equity raise and filed a clinical trial application for its lead psychedelic-assisted psychotherapy program, noted a Stifel report.
Tags:  Psychedelics

Second Half of 2023 Is Catalyst Rich for This Biopharma Co.

Research Report
  ()
The firm continues advancing its lead drug candidates, including those for anxiety and treatment-resistant depression, noted an H.C. Wainwright & Co. report.

Biotech Co. Completes Step Toward Psychedelic Treatment for Brain Injuries

  ()
Algernon Neuro has completed the third stage of its dosage trial for DMT as a treatment for traumatic brain injury. Read on to see how the company expects to take psychedelics into the mainstream.

Showing Results: 1 to 4 of 4